10 results
8-K
EX-99.1
PVCT
Provectus Biopharmaceuticals, Inc.
16 Apr 24
Provectus Biopharmaceuticals Announces Management Additions and Reiterates Commitment to Shareholder Value Creation
4:58pm
, employees, consultants, and clinical and research collaborators, we will continue to execute on our mission to develop and commercialize innovative
8-K
EX-99.1
PVCT
Provectus Biopharmaceuticals, Inc.
27 Mar 24
Entry into a Material Definitive Agreement
12:10pm
in such an innovative way is very rewarding. We look forward to working with Provectus to deliver this groundbreaking treatment to patients worldwide … through compassionate patient care and innovative research. For 2023-2024, U.S. News & World Report (“U.S. News”) ranked BPEI as the nation’s best
8-K
EX-99.1
PVCT
Provectus Biopharmaceuticals, Inc.
18 Aug 14
Regulation FD Disclosure
12:00am
team. The MOU provides that “the parties agreed that PV-10 is an advanced innovative drug representing the oncology research trend worldwide, [which
8-K
EX-99.1
vgl9jkb
13 Sep 13
Regulation FD Disclosure
12:00am
8-K
EX-99.2
lu4wkug j0b4d4
8 Apr 05
Other Events
12:00am
8-K
EX-99.1
g5e za7jomr5q
2 Dec 03
Other events
12:00am
10QSB/A
z13f5613
3 Sep 02
Quarterly report (small business) (amended)
12:00am
10QSB/A
fawg8frqdo2njgb
15 Aug 02
Quarterly report (small business) (amended)
12:00am
- Prev
- 1
- Next